These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7075441)

  • 1. Quantifications and sensitivity in bone scanning in the detection of bone metastases.
    Ritsema GH
    Diagn Imaging; 1982; 51(2):99-106. PubMed ID: 7075441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Whole-body retention of 99mTc-methylene diphosphonate in skeletal diseases].
    Zorn-Bopp E; Büll U; Münzing W; Lang P; Moser EA
    Nuklearmedizin; 1983 Feb; 22(1):24-30. PubMed ID: 6223277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of 24-hour whole-body retention of Tc-99mMDP with a thyroid uptake probe: quantitative assessment of metabolic and metastatic bone diseases.
    Seto H; Futatsuya R; Ihara F; Kamei T; Furumoto N; Ishizaki Y; Hada M; Kakishita M
    Radiat Med; 1984; 2(2):87-92. PubMed ID: 6240671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
    Fogelman I; Bessent RG; Turner JG; Citrin DL; Boyle IT; Greig WR
    J Nucl Med; 1978 Mar; 19(3):270-5. PubMed ID: 564941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scintigraphy with 99mTc-phosphonate and 67gallium in patients suspected of primary bone tumors.
    Edeling CJ
    Nuklearmedizin; 1982 Aug; 21(4):136-9. PubMed ID: 6959075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of quantitative and visual detection of new focal bone lesions.
    Pitt WR; Sharp PF
    J Nucl Med; 1985 Mar; 26(3):230-6. PubMed ID: 3156219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurement of 24-hr whole-body retention of 99mTc-MDP with a thyroid uptake probe (author's transl)].
    Seto H; Kakishita M; Futatsuya R
    Radioisotopes; 1981 May; 30(5):263-7. PubMed ID: 6458840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplified technique for quantifying 24-h whole body retention of 99mTc-labeled methylene diphosphonate (MDP).
    Castronovo FP; McKusick KA; Dann J; Prout GR; Strauss HW
    Int J Nucl Med Biol; 1985; 12(3):209-14. PubMed ID: 3877704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone-seeking radiopharmaceuticals in evaluating the treatment of skeletal metastases of malignant tumors].
    Naumenko AZ; Korsunskiĭ VN
    Med Radiol (Mosk); 1984 Mar; 29(3):27-30. PubMed ID: 6321881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of the superscan in prostatic bone scintigraphy.
    Constable AR; Cranage RW
    Br J Radiol; 1981 Feb; 54(638):122-5. PubMed ID: 7459549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Skeletal scintigraphy for the observation of course and treatment of carcinoma of the prostate ].
    Pabst HW; Langhammer H; Schmid L; Sintermann R
    Rofo; 1981 Jul; 135(1):44-9. PubMed ID: 6288532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Superscan].
    Lundorf E
    Ugeskr Laeger; 1985 Jan; 147(3):178-9. PubMed ID: 3992732
    [No Abstract]   [Full Text] [Related]  

  • 14. [The contribution of whole-body scintigraphy with Tc99m diphosphonate in neurosurgical examinations].
    Constantinovici A; Velula L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1983; 28(4):269-79. PubMed ID: 6229854
    [No Abstract]   [Full Text] [Related]  

  • 15. Radionuclide bone imaging.
    Bassett LW; Gold RH; Webber MM
    Radiol Clin North Am; 1981 Dec; 19(4):675-702. PubMed ID: 7034044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scintigraphic diagnosis of occult bone metastases in patients with operable breast cancer.
    Stanchev V; Grigorov L; Ouzounov I; Mitov F
    Folia Med (Plovdiv); 1986; 28(2):29-33. PubMed ID: 3108109
    [No Abstract]   [Full Text] [Related]  

  • 17. Radionuclide bone scanning in neuroblastoma: skeletal metastases and primary tumor localization of 99mTc-MDP.
    Podrasky AE; Stark DD; Hattner RS; Gooding CA; Moss AA
    AJR Am J Roentgenol; 1983 Sep; 141(3):469-72. PubMed ID: 6224402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative value of bone scintigraphy and computed tomography in determining bone involvement by soft-tissue sarcomas.
    Hudson TM; Schakel M; Springfield DS; Spanier SS; Enneking WF
    J Bone Joint Surg Am; 1984 Dec; 66(9):1400-7. PubMed ID: 6501336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased skeletal:renal uptake ratio: etiology and characteristics.
    Cheng TH; Holman BL
    Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radionuclide bone scanning of osteosarcoma: falsely extended uptake patterns.
    Chew FS; Hudson TM
    AJR Am J Roentgenol; 1982 Jul; 139(1):49-54. PubMed ID: 6283871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.